Vitamin K: Novel molecular mechanisms of action and its roles in osteoporosis

Geriatrics and Gerontology International

Volumn 14, Issue 1, 2014, Pages 1-7

  Azuma, Kotaro ^a,b   Ouchi, Yasuyoshi ^a   Inoue, Satoshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

glutamyl carboxylase; Pregnane X receptor; Steroid and xenobiotic receptor; VitaminK

Indexed keywords

CELL NUCLEUS RECEPTOR; MENADIONE EPOXIDE; OSTEOCALCIN; PREGNANE X RECEPTOR; REGULATOR PROTEIN; STEROID RECEPTOR; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K EPOXIDE REDUCTASE; VITAMIN K GROUP; WARFARIN; XENOBIOTIC AGENT;

ANTICOAGULANT THERAPY; ARTERIOSCLEROSIS; BLOOD CLOTTING; BONE DENSITY; BONE TISSUE; DEMENTIA; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENHANCER REGION; FRACTURE; GERIATRIC DISORDER; GERIATRICS; HUMAN; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TRABECULAR BONE;

PREGNANE X RECEPTOR; STEROID AND XENOBIOTIC RECEPTOR; VITAMIN K; Γ-GLUTAMYL CARBOXYLASE;

ANIMALS; BLOOD COAGULATION; HUMANS; OSTEOPOROSIS; VITAMIN K; VITAMINS;

EID: 84892371205     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12060     Document Type: Review

References (60)

1. Booth SL, Suttie JW. Dietary intake and adequacy of vitaminK. J Nutr 1998; 128: 785-788.
2. Okano T, Shimomura Y, Yamane M etal. Conversion of phylloquinone (VitaminK1) into menaquinone-4 (VitaminK2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 2008; 283: 11270-11279.
3. Thijssen HH, Drittij-Reijnders MJ. VitaminK status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br J Nutr 1996; 75: 121-127.
4. Lamson DW, Plaza SM. The anticancer effects of vitaminK. Altern Med Rev 2003; 8: 303-318.
5. Dam H. The antihemorrhagic vitamin of the chick: occurrence and chemical nature. Nature 1935; 135: 652-653.
6. Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitaminK. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem 1974; 249: 6347-6350.
7. Stenflo J, Fernlund P, Egan W, Roepstorff P. VitaminK dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A 1974; 71: 2730-2733.
8. Shiraki M, Shiraki Y, Aoki C, Miura M. VitaminK2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000; 15: 515-521.
9. Neogi T, Booth SL, Zhang YQ etal. Low vitaminK status is associated with osteoarthritis in the hand and knee. Arthritis Rheum 2006; 54: 1255-1261.
10. Presse N, Shatenstein B, Kergoat MJ, Ferland G. Low vitaminK intakes in community-dwelling elders at an early stage of Alzheimer's disease. J Am Diet Assoc 2008; 108: 2095-2099.
11. Geleijnse JM, Vermeer C, Grobbee DE etal. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105.
12. Gast GC, de Roos NM, Sluijs I etal. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009; 19: 504-510.
13. Nakagawa K, Hirota Y, Sawada N etal. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010; 468: 117-121.
14. Habu D, Shiomi S, Tamori A etal. Role of vitaminK2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA 2004; 292: 358-361.
15. Cheung AM, Tile L, Lee Y etal. VitaminK supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 2008; 5: e196.
16. Miyazawa K, Nishimaki J, Ohyashiki K etal. VitaminK2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan. Leukemia 2000; 14: 1156-1157.
17. Rezaie AR, Bae JS, Manithody C, Qureshi SH, Yang L. Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z. J Biol Chem 2008; 283: 19922-19926.
18. Varnum BC, Young C, Elliott G etal. Axl receptor tyrosine kinase stimulated by the vitaminK-dependent protein encoded by growth-arrest-specific gene 6. Nature 1995; 373: 623-626.
19. Worcester EM, Sebastian JL, Hiatt JG, Beshensky AM, Sadowski JA. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin. Calcif Tissue Int 1993; 53: 242-248.
20. Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A 1976; 73: 1447-1451.
21. Luo G, Ducy P, McKee MD etal. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
22. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. Periostin, a member of a novel family of vitaminK-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 2008; 283: 17991-18001.
23. Kulman JD, Harris JE, Haldeman BA, Davie EW. Primary structure and tissue distribution of two novel proline-rich gamma-carboxyglutamic acid proteins. Proc Natl Acad Sci U S A 1997; 94: 9058-9062.
24. Kulman JD, Harris JE, Xie L, Davie EW. Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. Proc Natl Acad Sci U S A 2001; 98: 1370-1375.
25. Viegas CS, Simes DC, Laizé V, Williamson MK, Price PA, Cancela ML. Gla-rich protein (GRP), a new vitaminK-dependent protein identified from sturgeon cartilage and highly conserved in vertebrates. J Biol Chem 2008; 283: 36655-36664.
26. Neacsu CD, Grosch M, Tejada M etal. Ucmaa (Grp-2) is required for zebrafish skeletal development. Evidence for a functional role of its glutamate γ-carboxylation. Matrix Biol 2011; 30: 369-378.
27. Eitzinger N, Surmann-Schmitt C, Bösl M etal. Ucma is not necessary for normal development of the mouse skeleton. Bone 2012; 50: 670-680.
28. Berkner KL, Pudota BN. VitaminK-dependent carboxylation of the carboxylase. Proc Natl Acad Sci U S A 1998; 95: 466-471.
29. McIntosh JM, Olivera BM, Cruz LJ, Gray WR. Gamma-carboxyglutamate in a neuroactive toxin. J Biol Chem 1984; 259: 14343-14346.
30. Warder SE, Prorok M, Chen Z etal. The roles of individual gamma-carboxyglutamate residues in the solution structure and cation-dependent properties of conantokin-T. J Biol Chem 1998; 273: 7512-7522.
31. Morris DP, Stevens RD, Wright DJ, Stafford DW. Processive post-translational modification. VitaminK-dependent carboxylation of a peptide substrate. J Biol Chem 1995; 270: 30491-30498.
32. Stafford DW. The vitaminK cycle. J Thromb Haemost 2005; 3: 1873-1878.
33. Blumberg B, Sabbagh W Jr, Juguilon H etal. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 1998; 12: 3195-3205.
34. Zhou C, Verma S, Blumberg B. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal 2009; 7: e001.
35. Staudinger JL, Goodwin B, Jones SA etal. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 2001; 98: 3369-3374.
36. Xie W, Radominska-Pandya A, Shi Y etal. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A 2001; 98: 3375-3380.
37. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 2001; 7: 584-590.
38. Miki Y, Suzuki T, Tazawa C, Blumberg B, Sasano H. Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 2005; 231: 75-85.
39. Albermann N, Schmitz-Winnenthal FH, Z'graggen K etal. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 2005; 70: 949-958.
40. Tabb MM, Sun A, Zhou C etal. VitaminK2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003; 278: 43919-43927.
41. Kaneki M, Hodges SJ, Hosoi T etal. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitaminK2: possible implications for hip-fracture risk. Nutrition 2001; 17: 315-321.
42. Yaegashi Y, Onoda T, Tanno K, Kuribayashi T, Sakata K, Orimo H. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitaminK. Eur J Epidemiol 2008; 23: 219-225.
43. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. VitaminK and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 1256-1261.
44. Zhu A, Sun H, Raymond RM Jr etal. Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase. Blood 2007; 109: 5270-5275.
45. Kinoshita H, Nakagawa K, Narusawa K etal. A functional single nucleotide polymorphism in the vitamin-K-dependent gamma-glutamyl carboxylase gene (Arg325Gln) is associated with bone mineral density in elderly Japanese women. Bone 2007; 40: 451-456.
46. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997; 82: 719-724.
47. Ducy P, Desbois C, Boyce B etal. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452.
48. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000; 160: 191-196.
49. Barnes C, Newall F, Ignjatovic V etal. Reduced bone density in children on long-term warfarin. Pediatr Res 2005; 57: 578-581.
50. Jamal SA, Browner WS, Bauer DC, Cummings SR. Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1998; 128: 829-832.
51. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 2006; 166: 241-246.
52. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S. Steroid and xenobiotic receptor SXR mediates vitaminK2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem 2006; 281: 16927-16934.
53. Ohta K, Lupo G, Kuriyama S etal. Tsukushi functions as an organizer inducer by inhibition of BMP activity in cooperation with chordin. Dev Cell 2004; 7: 347-358.
54. Wagener R, Ehlen HW, Ko YP etal. The matrilins-adaptor proteins in the extracellular matrix. FEBS Lett 2005; 579: 3323-3329.
55. Roman-Roman S, Garcia T, Jackson A etal. Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 2003; 32: 474-482.
56. Filipp D, Alizadeh-Khiavi K, Richardson C etal. Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. Proc Natl Acad Sci U S A 2001; 98: 603-608.
57. Manabe N, Kawaguchi H, Chikuda H etal. Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 2001; 167: 2625-2631.
58. Igarashi M, Yogiashi Y, Mihara M, Takada I, Kitagawa H, Kato S. VitaminK induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene. Mol Cell Biol 2007; 27: 7947-7954.
59. Azuma K, Casey SC, Ito M etal. Pregnane X receptor knockout mice display osteopenia with reduced bone formation and enhanced bone resorption. J Endocrinol 2010; 207: 257-263.
60. Zhou C, Tabb MM, Nelson EL etal. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 2006; 116: 2280-2289.